Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ALPS Group's gross profit for the
six
months ended in Mar. 2026 was $4.86 Mil. ALPS Group's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was $4.86 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. ALPS Group's gross profit for the
six
months ended in Mar. 2026 was $4.86 Mil. ALPS Group's Revenue for the
six
months ended in Mar. 2026 was $4.86 Mil. Therefore, ALPS Group's Gross Margin % for the quarter that ended in Mar. 2026 was N/A%.
ALPS Group had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
During the past 4 years, the highestGross Margin % of ALPS Group was 54.99%. The lowest was 24.92%. And the median was 35.34%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
ALPS Group had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
ALPS Group Gross Profit Related Terms
ALPS Group Gross Profit Historical Data
* Premium members only.
The historical data trend for ALPS Group's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, ALPS Group's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ALPS Group Gross Profit vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ALPS Group's Gross Profit distribution charts can be found below:
* The bar in red indicates where ALPS Group's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.86 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
(Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
ALPS Group (ALPS) has a Gross Profit of $4.86 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on ALPS Group and its competitors.
Is ALPS Group's Gross Profit too high?
ALPS Group's current Gross Profit is $4.86 Mil. Overall, ALPS Group has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does ALPS Group's Gross Profit compare to OKYO and CGTX?
ALPS Group's Gross Profit of $4.86 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Biotechnology company?
A good Gross Profit depends on the Biotechnology industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on ALPS Group and its competitors. ALPS Group's current Gross Profit is $4.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ALPS Group stock overvalued right now?
ALPS Group (ALPS) has a current Gross Profit of $4.86 Mil. The current Gross Profit is $4.86 Mil. ALPS Group's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For ALPS Group (ALPS), the current Gross Profit is $4.86 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
10GF Score
Get the complete analysis for ALPS
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALPS has been successfully added to your 
